217 related articles for article (PubMed ID: 8468723)
1. Psychological impact of screening for familial ovarian cancer.
Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S
J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723
[TBL] [Abstract][Full Text] [Related]
2. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.
Hensley ML; Robson ME; Kauff ND; Korytowsky B; Castiel M; Ostroff J; Hurley K; Hann LE; Colon J; Spriggs D
Gynecol Oncol; 2003 Jun; 89(3):440-6. PubMed ID: 12798709
[TBL] [Abstract][Full Text] [Related]
3. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
Bourne TH; Campbell S; Reynolds KM; Whitehead MI; Hampson J; Royston P; Crayford TJ; Collins WP
BMJ; 1993 Apr; 306(6884):1025-9. PubMed ID: 8490496
[TBL] [Abstract][Full Text] [Related]
4. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound screening for familial ovarian cancer.
Bourne TH; Whitehead MI; Campbell S; Royston P; Bhan V; Collins WP
Gynecol Oncol; 1991 Nov; 43(2):92-7. PubMed ID: 1743564
[TBL] [Abstract][Full Text] [Related]
7. Psychological response to test results in an ovarian cancer screening program: a prospective, longitudinal study.
Andrykowski MA; Boerner LM; Salsman JM; Pavlik E
Health Psychol; 2004 Nov; 23(6):622-30. PubMed ID: 15546230
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
[TBL] [Abstract][Full Text] [Related]
9. Transabdominal ultrasound screening for early ovarian cancer.
Campbell S; Bhan V; Royston P; Whitehead MI; Collins WP
BMJ; 1989 Dec; 299(6712):1363-7. PubMed ID: 2513964
[TBL] [Abstract][Full Text] [Related]
10. Screening postmenopausal women for ovarian cancer: a systematic review.
Fung MF; Bryson P; Johnston M; Chambers A;
J Obstet Gynaecol Can; 2004 Aug; 26(8):717-28. PubMed ID: 15307976
[TBL] [Abstract][Full Text] [Related]
11. The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer.
Bourne TH; Campbell S; Reynolds K; Hampson J; Bhatt L; Crayford TJ; Whitehead MI; Collins WP
Gynecol Oncol; 1994 Mar; 52(3):379-85. PubMed ID: 8157195
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial.
Taylor KL; Shelby R; Gelmann E; McGuire C
J Natl Cancer Inst; 2004 Jul; 96(14):1083-94. PubMed ID: 15265970
[TBL] [Abstract][Full Text] [Related]
13. A qualitative study of women's experiences of familial ovarian cancer screening.
Lifford KJ; Clements A; Fraser L; Lancastle D; Brain K;
Psychooncology; 2013 Nov; 22(11):2576-84. PubMed ID: 23801640
[TBL] [Abstract][Full Text] [Related]
14. False-positive cancer screens and health-related quality of life.
McGovern PM; Gross CR; Krueger RA; Engelhard DA; Cordes JE; Church TR
Cancer Nurs; 2004; 27(5):347-52. PubMed ID: 15525861
[TBL] [Abstract][Full Text] [Related]
15. Illness representations and distress in women undergoing screening for familial ovarian cancer.
Lancastle D; Brain K; Phelps C
Psychol Health; 2011 Dec; 26(12):1659-77. PubMed ID: 21736431
[TBL] [Abstract][Full Text] [Related]
16. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Madalinska JB; Hollenstein J; Bleiker E; van Beurden M; Valdimarsdottir HB; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2005 Oct; 23(28):6890-8. PubMed ID: 16129845
[TBL] [Abstract][Full Text] [Related]
17. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands.
Scaf-Klomp W; Sanderman R; van de Wiel HB; Otter R; van den Heuvel WJ
J Epidemiol Community Health; 1997 Dec; 51(6):705-10. PubMed ID: 9519137
[TBL] [Abstract][Full Text] [Related]
18. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.
Tiller K; Meiser B; Butow P; Clifton M; Thewes B; Friedlander M; Tucker K
Gynecol Oncol; 2002 Aug; 86(2):212-9. PubMed ID: 12144830
[TBL] [Abstract][Full Text] [Related]
19. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME
J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer screening by transvaginal color Doppler ultrasonography.
Rampone B; Rampone A; Tirabasso S; Panariello S; Rampone N
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):125-8. PubMed ID: 11526707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
